- Home
- AMBP vs RGC Comparison
AMBP vs RGC Comparison
Compare AMBP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMBP | RGC |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | Luxembourg | Hong Kong |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMBP | RGC |
|---|---|---|
| Price | $4.38 | $6.15 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.39 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 161.3K |
| Earning Date | 04-23-2026 | 10-31-2025 |
| Dividend Yield | ★ 10.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.31 | N/A |
| Revenue Next Year | $2.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.29 | $4.51 |
| 52 Week High | $5.47 | $69.00 |
Technical Indicators
Market Signals| Indicator | AMBP | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 29.09 | 53.17 |
| Support Level | $3.87 | $5.48 |
| Resistance Level | $4.95 | $6.22 |
| Average True Range (ATR) | 0.13 | 0.42 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 10.95 | 41.64 |
Price Performance
Historical ComparisonAbout AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. The geographical segments of the company includes Europe and the Americas. Geographically, the company derives a majority of its revenue from the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.